Credit Suisse Downgrades Diplomat Pharmacy (DPLO) to Underperform

January 16, 2020 4:52 AM EST Send to a Friend
Credit Suisse analyst A.J. Rice downgraded Diplomat Pharmacy (NYSE: DPLO) from Neutral to Underperform with a price target of $4.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login